This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Case Study – Unidose Nasal Spray Pump for Epilepsy
Case Studies, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
Building Digital Solutions To Meet The Unique Therapeutic Needs of Patients
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions
Drug Repositioning – Benefits and Challenges for Lifecycle Management
Webinars, Pharmaceutical, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions
Step to Success in Nose-to-Brain Drug Delivery
Publications, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions
